Long-term aminobisphosphonate treatment of fibrous dysplasia: Spectacular increase in bone density

Journal of Bone and Mineral Research

Volumn 12, Issue 8, 1997, Pages 1314-1315

  Weinstein, R S ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ALBRIGHT SYNDROME; ARTICLE; BONE DENSITY; DRUG EFFECT; FIBROUS DYSPLASIA; HUMAN; OSTEOBLAST;

EID: 0030739918     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1997.12.8.1314     Document Type: Article

References (6)

1. 1 Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM 1991 Activating mutations of the stimulatory G protein in the McCune‐Albright syndrome N Engl J Med 325: 1688–1695; 1738‐1740 (editorial).
2. 2 Shenker A, Weinstein LS, Sweet DE, Spiegel AM 1994 An activating G s α mutation is present in fibrous dysplasia of bone in the McCune‐Albright syndrome J Clin Endocrinol Metab 79: 750–755.
3. 3 Yamamoto T, Ozono K, Kasayama S, Yoh K, Hiroshima K, Takagi M, Matsumoto S, Michigami T, Yamaoka K, Kishimoto T, Okada S 1996 Increased IL‐6 production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune‐Albright syndrome J Clin Invest 98: 30–35.
4. 4 Candeliere GA, Glorieux FH, Prud'homme J, St.‐Arnaud R 1995 Increased expression of the c‐fos proto‐oncogene in bone marrow from patients with fibrous dysplasia N Engl J Med 352: 1546–1551.
5. 5 Kaplan FS, Fallon MD, Boden SD, Schmidt R, Senior M, Haddad JG 1988 Estrogen receptors in bone in a patient with polyostotic fibrous dysplasia (McCune‐Albright syndrome) N Engl J Med 319: 421–425.
6. 6 Liens D, Delmas PD, Meunier PJ 1994 Long‐term effects of intravenous pamidronate in fibrous dysplasia of bone Lancet 343: 953–954.